Impact of prostate volume on the active surveillance in prostate cancer

被引:0
|
作者
Beaujouan, Florent [1 ]
Bertherat, Walter [2 ]
Hammoudi, Zakaria [1 ]
Chicaud, Marie [1 ]
Descazeaud, Aurelien [1 ]
机构
[1] Univ Hosp Ctr Dupuytren, Dept Urol Surg & Androl, 16 rue Petiniaud-Beaupeyrat, F-87000 Limoges, France
[2] Perigueux Hosp Ctr, Dept Urol Surg & Androl, Perigueux, France
关键词
Prostatic neoplasms; active surveillance; prostate-specific antigen; prostatic hyperplasia; prognostic factors; FOLLOW-UP; ANTIGEN KINETICS; GUIDELINES; MANAGEMENT; DIAGNOSIS; OUTCOMES; PREDICT; UPDATE; BIOPSY; COHORT;
D O I
10.1177/20514158241303972
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the influence of the prostate volume (PVo) in the management of patients in active surveillance (AS) for prostate cancer. Materials and methods: A retrospective analysis of clinical, biological, histological and radiological data collected between 2010 and 2021 was performed for patients included in an AS protocol in a university hospital. The impact of initial PVo on the subsequent risk of exiting AS was evaluated. Results: In total, 109 patients were included in this analysis with a mean follow-up period of 52.74 +/- 31 months, 50% were out of AS by the end of the follow-up period. The risk of exiting the AS protocol was significantly associated to the PVo: patients with smaller PVo had an increased risk of exiting AS (p = 0.025). The maximal percentage of core invasion was the only initial predictive parameter for exiting the AS protocol on multivariate analysis of the global cohort (p = 0.010) and in the sub-group of patients having PVo <= 45 mL (p = 0.013). In the group having a PVo > 45 mL, no single initial parameter was significantly associated to a risk of exiting AS. Conclusion: Patients having small-sized prostate seemed to be at higher risk of exiting AS during follow-up.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Active surveillance of prostate cancer
    Hammerer, Peter
    Manka, Lukas
    ONKOLOGE, 2020, 26 (11): : 1069 - 1078
  • [42] The utility of prostate MRI within active surveillance: description of the evidence
    Dominique, Georgina
    Brisbane, Wayne G.
    Reiter, Robert E.
    WORLD JOURNAL OF UROLOGY, 2022, 40 (01) : 71 - 77
  • [43] Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing
    Overholser, Stephen
    Nielsen, Matthew
    Torkko, Kathleen
    Cwilka, Daniel
    Weaver, Brandi
    Shi, Xiaoyu
    Leach, Robin J.
    Hernandez, Javier
    Huang, Tim
    Thompson, Ian M., Jr.
    Thompson, Ian M., III
    JOURNAL OF UROLOGY, 2015, 194 (03) : 680 - 684
  • [44] Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan
    Kato, Takuma
    Hirama, Hiromi
    Kamoto, Toshiyuki
    Goto, Takayuki
    Fujimoto, Hiroyuki
    Sakamoto, Shinichi
    Shinohara, Nobuo
    Egawa, Shin
    Kouguchi, Dai
    Nakayama, Masashi
    Hashine, Katsuyoshi
    Shimizu, Nobuaki
    Inoue, Koji
    Habuchi, Tomonori
    Hioka, Takaya
    Shiraishi, Taizou
    Sugimoto, Mikio
    Kakehi, Yoshiyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (10) : 1557 - 1563
  • [45] Active surveillance or prostate cancer
    Mottet, N.
    ONCOLOGIE, 2012, 14 (02) : 74 - 78
  • [46] Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance
    Tosoian, Jeffrey J.
    Mamawala, Mufaddal
    Patel, Hiten D.
    Alam, Ridwan
    Epstein, Jonathan I.
    Ross, Ashley E.
    Carter, Ballentine
    JOURNAL OF UROLOGY, 2018, 199 (04) : 954 - 959
  • [47] Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator
    Ankerst, Donna P.
    Xia, Jing
    Thompson, Ian M., Jr.
    Hoefler, Josef
    Newcomb, Lisa F.
    Brooks, James D.
    Carroll, Peter R.
    Ellis, William J.
    Gleave, Martin E.
    Lance, Raymond S.
    Nelson, Peter S.
    Wagner, Andrew A.
    Wei, John T.
    Etzioni, Ruth
    Lin, Daniel W.
    EUROPEAN UROLOGY, 2015, 68 (06) : 1083 - 1088
  • [48] Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance
    Eltemamy, Mohamed M.
    Leapman, Michael S.
    Cowan, Janet E.
    Westphalen, Antonio
    Shinohara, Katsuto
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2016, 196 (03) : 727 - 732
  • [49] Validation of active surveillance criteria for pathologically insignificant prostate cancer in Asian men
    Yamada, Yasutaka
    Sakamoto, Shinichi
    Sazuka, Tomokazu
    Goto, Yusuke
    Kawamura, Koji
    Imamoto, Takashi
    Nihei, Naoki
    Suzuki, Hiroyoshi
    Akakura, Koichiro
    Ichikawa, Tomohiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (01) : 49 - 54
  • [50] Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice
    Herden, Jan
    Weissbach, Lothar
    WORLD JOURNAL OF UROLOGY, 2018, 36 (03) : 383 - 391